HEADER TRANSFERASE 11-NOV-21 7Q8V TITLE CRYSTAL STRUCTURE OF TTBK1 IN COMPLEX WITH VNG2.73 (COMPOUND 42) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TAU-TUBULIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BRAIN-DERIVED TAU KINASE; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTBK1, BDTK, KIAA1855; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: -R3-PRARE2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PSUMO-LIC KEYWDS KINASE, TTBK1, TAU TUBULIN KINASE, KINASE INHIBITOR, STRUCTURAL KEYWDS 2 GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.CHAIKUAD,V.NOZAL,A.MARTINEZ,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (SGC) REVDAT 2 31-JAN-24 7Q8V 1 REMARK REVDAT 1 09-MAR-22 7Q8V 0 JRNL AUTH V.NOZAL,L.MARTINEZ-GONZALEZ,M.GOMEZ-ALMERIA, JRNL AUTH 2 C.GONZALO-CONSUEGRA,P.SANTANA,A.CHAIKUAD,E.PEREZ-CUEVAS, JRNL AUTH 3 S.KNAPP,D.LIETHA,D.RAMIREZ,S.PETRALLA,B.MONTI,C.GIL, JRNL AUTH 4 A.MARTIN-REQUERO,V.PALOMO,E.DE LAGO,A.MARTINEZ JRNL TITL TDP-43 MODULATION BY TAU-TUBULIN KINASE 1 INHIBITORS: A NEW JRNL TITL 2 AVENUE FOR FUTURE AMYOTROPHIC LATERAL SCLEROSIS THERAPY. JRNL REF J.MED.CHEM. V. 65 1585 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 34978799 JRNL DOI 10.1021/ACS.JMEDCHEM.1C01942 REMARK 2 REMARK 2 RESOLUTION. 2.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 16685 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 899 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.13 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.19 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1218 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.78 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 76 REMARK 3 BIN FREE R VALUE : 0.3080 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2380 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 75 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.56000 REMARK 3 B22 (A**2) : 2.11000 REMARK 3 B33 (A**2) : -2.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.17000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.249 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.207 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.158 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.648 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2463 ; 0.012 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2370 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3310 ; 1.298 ; 1.643 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5439 ; 1.206 ; 1.594 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 291 ; 8.140 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 141 ;34.009 ;20.993 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 457 ;14.690 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;21.594 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 295 ; 0.061 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2879 ; 0.013 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 613 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 21 A 109 REMARK 3 ORIGIN FOR THE GROUP (A): 71.1414 39.1243 9.5007 REMARK 3 T TENSOR REMARK 3 T11: 0.0549 T22: 0.1727 REMARK 3 T33: 0.1272 T12: -0.0014 REMARK 3 T13: -0.0052 T23: -0.0179 REMARK 3 L TENSOR REMARK 3 L11: 3.5021 L22: 4.3163 REMARK 3 L33: 2.6999 L12: 0.6449 REMARK 3 L13: 0.0582 L23: 0.6808 REMARK 3 S TENSOR REMARK 3 S11: 0.1252 S12: -0.2770 S13: 0.3605 REMARK 3 S21: 0.1452 S22: -0.0307 S23: 0.3090 REMARK 3 S31: -0.2261 S32: -0.2242 S33: -0.0946 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 110 A 312 REMARK 3 ORIGIN FOR THE GROUP (A): 59.2289 31.0786 -12.0024 REMARK 3 T TENSOR REMARK 3 T11: 0.0199 T22: 0.0520 REMARK 3 T33: 0.0516 T12: 0.0180 REMARK 3 T13: -0.0179 T23: -0.0438 REMARK 3 L TENSOR REMARK 3 L11: 3.6063 L22: 1.6130 REMARK 3 L33: 2.1767 L12: 0.2342 REMARK 3 L13: -0.6142 L23: -0.0835 REMARK 3 S TENSOR REMARK 3 S11: 0.0548 S12: 0.3043 S13: -0.1027 REMARK 3 S21: -0.1564 S22: -0.0321 S23: 0.0389 REMARK 3 S31: -0.0112 S32: -0.0213 S33: -0.0227 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 7Q8V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1292119189. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JUL-21 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00002 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17584 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.130 REMARK 200 RESOLUTION RANGE LOW (A) : 47.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.13 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.90300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7JXX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 29% PEG 3350, 0.2M SODIUM ACETATE, REMARK 280 0.1M TRIS 8.5, PH 8.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 85.45750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.75950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 85.45750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.75950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 12 REMARK 465 ASN A 13 REMARK 465 MET A 14 REMARK 465 SER A 15 REMARK 465 GLY A 16 REMARK 465 GLY A 17 REMARK 465 GLY A 18 REMARK 465 GLU A 19 REMARK 465 GLN A 20 REMARK 465 ALA A 313 REMARK 465 GLY A 314 REMARK 465 THR A 315 REMARK 465 ASP A 316 REMARK 465 ALA A 317 REMARK 465 LEU A 318 REMARK 465 LEU A 319 REMARK 465 SER A 320 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 27 -0.87 76.19 REMARK 500 ARG A 33 -51.73 -142.78 REMARK 500 ARG A 57 -0.58 88.25 REMARK 500 GLN A 69 115.91 -22.58 REMARK 500 ASN A 99 -176.64 179.44 REMARK 500 ASP A 154 50.70 -144.04 REMARK 500 THR A 168 -6.34 -140.95 REMARK 500 ASN A 185 -155.82 -77.72 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Q8V A 13 320 UNP Q5TCY1 TTBK1_HUMAN 13 320 SEQADV 7Q8V MET A 12 UNP Q5TCY1 INITIATING METHIONINE SEQRES 1 A 309 MET ASN MET SER GLY GLY GLY GLU GLN ALA ASP ILE LEU SEQRES 2 A 309 PRO ALA ASN TYR VAL VAL LYS ASP ARG TRP LYS VAL LEU SEQRES 3 A 309 LYS LYS ILE GLY GLY GLY GLY PHE GLY GLU ILE TYR GLU SEQRES 4 A 309 ALA MET ASP LEU LEU THR ARG GLU ASN VAL ALA LEU LYS SEQRES 5 A 309 VAL GLU SER ALA GLN GLN PRO LYS GLN VAL LEU LYS MET SEQRES 6 A 309 GLU VAL ALA VAL LEU LYS LYS LEU GLN GLY LYS ASP HIS SEQRES 7 A 309 VAL CYS ARG PHE ILE GLY CYS GLY ARG ASN GLU LYS PHE SEQRES 8 A 309 ASN TYR VAL VAL MET GLN LEU GLN GLY ARG ASN LEU ALA SEQRES 9 A 309 ASP LEU ARG ARG SER GLN PRO ARG GLY THR PHE THR LEU SEQRES 10 A 309 SER THR THR LEU ARG LEU GLY LYS GLN ILE LEU GLU SER SEQRES 11 A 309 ILE GLU ALA ILE HIS SER VAL GLY PHE LEU HIS ARG ASP SEQRES 12 A 309 ILE LYS PRO SER ASN PHE ALA MET GLY ARG LEU PRO SER SEQRES 13 A 309 THR TYR ARG LYS CYS TYR MET LEU ASP PHE GLY LEU ALA SEQRES 14 A 309 ARG GLN TYR THR ASN THR THR GLY ASP VAL ARG PRO PRO SEQRES 15 A 309 ARG ASN VAL ALA GLY PHE ARG GLY THR VAL ARG TYR ALA SEQRES 16 A 309 SER VAL ASN ALA HIS LYS ASN ARG GLU MET GLY ARG HIS SEQRES 17 A 309 ASP ASP LEU TRP SER LEU PHE TYR MET LEU VAL GLU PHE SEQRES 18 A 309 ALA VAL GLY GLN LEU PRO TRP ARG LYS ILE LYS ASP LYS SEQRES 19 A 309 GLU GLN VAL GLY MET ILE LYS GLU LYS TYR GLU HIS ARG SEQRES 20 A 309 MET LEU LEU LYS HIS MET PRO SER GLU PHE HIS LEU PHE SEQRES 21 A 309 LEU ASP HIS ILE ALA SER LEU ASP TYR PHE THR LYS PRO SEQRES 22 A 309 ASP TYR GLN LEU ILE MET SER VAL PHE GLU ASN SER MET SEQRES 23 A 309 LYS GLU ARG GLY ILE ALA GLU ASN GLU ALA PHE ASP TRP SEQRES 24 A 309 GLU LYS ALA GLY THR ASP ALA LEU LEU SER HET PO4 A 401 5 HET 9IV A 402 24 HETNAM PO4 PHOSPHATE ION HETNAM 9IV ~{N}-[4-(2-CHLORANYLPHENOXY)PHENYL]-7~{H}-PYRROLO[2,3- HETNAM 2 9IV D]PYRIMIDIN-4-AMINE FORMUL 2 PO4 O4 P 3- FORMUL 3 9IV C18 H13 CL N4 O FORMUL 4 HOH *75(H2 O) HELIX 1 AA1 VAL A 73 LEU A 84 1 12 HELIX 2 AA2 ASN A 113 GLN A 121 1 9 HELIX 3 AA3 THR A 127 VAL A 148 1 22 HELIX 4 AA4 LYS A 156 SER A 158 5 3 HELIX 5 AA5 SER A 207 LYS A 212 1 6 HELIX 6 AA6 GLY A 217 GLY A 235 1 19 HELIX 7 AA7 ASP A 244 TYR A 255 1 12 HELIX 8 AA8 GLU A 256 LYS A 262 5 7 HELIX 9 AA9 GLU A 267 LEU A 278 1 12 HELIX 10 AB1 ASP A 285 GLU A 299 1 15 SHEET 1 AA1 6 VAL A 29 VAL A 30 0 SHEET 2 AA1 6 TRP A 34 GLY A 41 -1 O TRP A 34 N VAL A 30 SHEET 3 AA1 6 GLU A 47 ASP A 53 -1 O MET A 52 N LYS A 35 SHEET 4 AA1 6 ASN A 59 SER A 66 -1 O LEU A 62 N TYR A 49 SHEET 5 AA1 6 PHE A 102 GLN A 108 -1 O MET A 107 N ALA A 61 SHEET 6 AA1 6 PHE A 93 GLY A 97 -1 N GLY A 95 O VAL A 106 SHEET 1 AA2 2 PHE A 150 LEU A 151 0 SHEET 2 AA2 2 ARG A 181 GLN A 182 -1 O ARG A 181 N LEU A 151 SHEET 1 AA3 2 PHE A 160 MET A 162 0 SHEET 2 AA3 2 CYS A 172 MET A 174 -1 O TYR A 173 N ALA A 161 CRYST1 170.915 39.519 49.037 90.00 103.08 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005851 0.000000 0.001359 0.00000 SCALE2 0.000000 0.025304 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020936 0.00000